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Cost and Expected Visual Effect of Interventions
to Improve Follow-up After Cataract Surgery
Prospective Review of Early Cataract Outcomes
and Grading (PRECOG) Study
Mirjam E. Meltzer, PhD; Nathan Congdon, MD, MPH; StevenM. Kymes, PhD; Xixi Yan, MD; Van C. Lansingh, MD; Alemayehu Sisay, MD;
Andreas Müller, PhD; Ving Fai Chan, MSc; Ling Jin, MS; Sasipriya M. Karumanchi, MHM; Chunhong Guan, MSc; Quy Vuong, MD;
Nelson Rivera, OD; JoanMcCleod-Omawale, PhD; Mingguang He, MD
IMPORTANCE Some experts recommend increasing low rates of follow-up after cataract
surgery in low- andmiddle-income countries using various interventions. However, little is
known about the cost and effect of such interventions.
OBJECTIVE To examine whether promoting follow-up after cataract surgery creates economic
value.
DESIGN, SETTING, AND PARTICIPANTS The Prospective Review of Early Cataract Outcomes
and Grading (PRECOG) is a cohort study with data from patients undergoing cataract surgery
from January 19, 2010, to April 18, 2012. Final follow-up was completed on August 10, 2012.
Data were collected before surgery, at discharge, and at follow-up at least 40 days after
surgery from 27 centers in 8 countries in Asia, Africa, and Latin America. Each center enrolled
40 to 120 consecutive patients undergoing cataract surgery. If patients did not return to the
hospital for the follow-up visit, hospitals could use telephone calls or transportation subsidies
to increase follow-up rate. Data were analyzed fromDecember 2013 to January 2016.
MAIN OUTCOMES ANDMEASURES Cost of interventions (telephone calls and transportation
subsidies) to increase follow-up at least 40 days after surgery, visual acuity (VA) in the eye
undergoing cataract surgery, presence of complications, patient and facility costs per visit,
and willingness to pay for treatment or glasses if needed. Themaximum incremental cost of
improving VA in 1 patient (incremental cost-effect ratio [ICER]) was calculated for
spontaneous follow-up (compared with no follow-up) and follow-up with the telephone and
transportation interventions. Expected ICERs were estimated including only those patients
willing to pay.
RESULTS Among 2487 patients (1068men [42.9%]; 1405 women [56.5%]; 14 missing
[0.6%]; mean [SD] age, 68.4 [11.3] years), 2316 (93.1%) received follow-up, of whom 369
(16.0%) were seen in an outside facility or home and were in the cost-effectiveness analysis
as unable to follow up. A grandmean (a mean of means of the different countries) of 56.3%
of patients needed glasses, of whom 56.9%were willing to pay, and 1.6% had treatable
complications, of whom 39.4%were willing to pay. Maximum proportions with improved VA
(and corresponding ICERs) were 0.08 for no follow-up, 0.45 ($151.56) for spontaneous
follow-up, 0.53 ($164.46) for a telephone intervention, and 0.53 ($133.07) for a
transportation intervention. These results were most sensitive to the cost of follow-up.
Expected proportions (ICERs) were 0.08, 0.27 ($232.69), 0.30 ($456.22), and 0.30
($206.47), respectively.
CONCLUSIONS AND RELEVANCE Most patients benefiting from follow-up after cataract
surgery returned spontaneously when requested at discharge. Use of telephone calls or
transportation subsidies to increase follow-up in low- andmiddle-income countries may not
be cost-effective.
JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2016.4735
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C ataract is the leading cause of blindness and visual im-pairment in lower- and middle-income countries(LMICs) and is responsible for the most disability-
adjusted life-years due to visual loss globally.1,2 Cataract sur-
gery often achieves excellent visual outcomes with low rates
of complication.3,4 However, in LMICs, cataract surgical cov-
erage is often low, and visual outcomes may be poor,1,5-8 es-
pecially owing tooperative complications anduncorrected re-
fractive errors, bothofwhich require postoperative follow-up
for diagnosis and treatment.4,8-12 Unfortunately, even short-
term (<6weeks) follow-up rates after cataract surgery are less
than 50% in many regions in LMICs and may fall below
30%.13,14
Investigators14-17havesuggestedthat improvementofpost-
operativefollow-upiscritical toenhancingcataractsurgicalout-
comes. A previous report,14 based on data from 40 centers in
LMICsintheProspectiveReviewofEarlyCataractOutcomesand
Grading (PRECOG) study, found that earlyassessmentofvision
after cataract surgery is anaccurate indicatorof surgicalquality
where follow-up rates are low. Although postoperative follow-
upmaynotbe required toassessoutcomequality,understand-
ingwhetherfollow-upcontributesto improvingvisualoutcomes
and whether patients who would benefit from follow-up are
among those returning spontaneously is important.Weherein
presentanalysesfromPRECOGdataexaminingwhetherpromot-
ingfollow-upaftercataractsurgerywithtelephonecallsor trans-
portationsubsidiescreateseconomicvaluefromtheperspective
of society or the patient.
Methods
ThemethodsforthePRECOGstudyhavebeenreportedindetail14
andaresummarizedherein.Hospitals fromAsia,LatinAmerica,
andAfricaweresolicitedtoparticipatethroughinternationalnon-
governmental organizations focusedoneyehealth. Theproto-
col for thePRECOGstudywasapprovedby the institutional re-
viewboard at the coordinating center (ZhongshanOphthalmic
Center,Guangzhou,China) and thoseofotherparticipatingor-
ganizations (listedat theendof thearticle).Allparticipantspro-
videdwritten informedconsent, and theprinciples of theDec-
laration of Helsinkiwere followed throughout.
Patient Enrollment
Eachhospital enrolled40 to 120consecutivepatients 30years
or older undergoing surgery for visually significant adult-
onset cataract. Patients could have any level of visual acuity
(VA) in theeyeundergoingsurgerydeemedappropriate for sur-
gery by local physicians but could not have apparent preop-
erative ocular comorbidities.
Preoperative Examination
All patients underwent preoperative ocular examinations by
an ophthalmologist or an ophthalmic clinical officer using a
slitlampwith dilation of the pupil. Data reported for each pa-
tient included demographic information, history of cataract
surgery, uncorrectedVA (UCVA) andbest-correctedVA (BCVA)
in both eyes, the presence of ocular comorbidities, and bio-
metricmeasurements todetermine thepowerof the intraocu-
lar lens for surgery.
TheVA for each eyewas assessed at each hospital using its
usual charts (tumbling E in all cases) at the recommended dis-
tance,usually4.0m.After correctly identifying thedirectionof
mostoftheoptotypesontheuppermostline(usuallycorrespond-
ing toVAof 3/60), patientsmoved to thenext and successively
lower lines.The lowest line inwhichmostof theoptoptypeswas
correctly readwas recorded as the patient’s VA.
Early Postoperative Examination
Theearlypostoperativeexaminationwascompletedwithin72
hours after surgery, at hospital discharge inmost centers.Data
recorded includedUCVAandBCVA in the eyeundergoing sur-
geryand the intraoperativeorperioperative complications.All
participants were instructed to return for a final examination
at least 40 days after surgery, with earlier visits at the discre-
tion of the facility.
Final Examination
Final examinationswereperformedonall participants return-
ing spontaneously to the hospital at least 40 days after sur-
gery.Fortydaysafter enrolling the final patient, a facility could
use telephone calls alone or in combination with transporta-
tion subsidies to encourage unexamined participants to re-
turn. At least 3months after enrolling the final patient, facili-
ties began home visits for unexamined patients, with a target
of examining at least 90% of enrollees. Clinics maintained a
log recording whether a patient had returned spontaneously
or after a study intervention or was examined at home.
The final examination included pupil dilation and slit-
lampexaminationbyanophthalmologist.TheUCVAandBCVA
in the eye undergoing surgery and the presence and type of
postoperative complications were collected. Complications
were categorized by the principal investigator (N.C.) as treat-
able by medication, treatable by incisional surgery or laser
therapy, or not treatable.
Patients whose distance VA in the eye undergoing sur-
gery improved by at least 2 lines with refraction were
defined as needing glasses. Patients were asked if they had
Key Points
Question Are interventions to increase low rates of follow-up
after cataract surgery in low- andmiddle-income countries
cost-effective?
Findings In this cohort of 2316 patients who attended follow-up
after cataract surgery in 8 countries in Asia, Africa, and Latin
America, the maximum proportions whose visual acuity might
improve with glasses or necessary treatment after surgery and the
corresponding incremental cost of improving visual acuity in 1
patient were increased from no follow-up to spontaneous
follow-up. A telephone intervention and transportation subsidies
to increase follow-up rates were not cost-effective.
Meaning Telephone calls or transport subsidies to increase
follow-up in low- andmiddle-income countries may not be
cost-effective; instead, patients should be reminded at the time of
surgery to return for follow-up.
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been offered glasses at a previous visit and for what price; if
not, whether they would accept glasses; and if so, the price
they were willing to pay (selected from among 4 locally rel-
evant options). Patients who had visually significant opera-
tive complications amenable to medical or surgical treat-
ment were asked whether they would accept treatment,
and, if so, to select the amount they were willing to pay.
Patient and Hospital Costs
All patientswere asked to estimate their total cost for a return
hospital visit, including transportation, food, lodging, and lost
income for themselves and any accompanying persons. Fa-
cilities provided information on their total cost of a postop-
erative visit (including labor and facility costs, such as elec-
tricity and consumables) and cost per patient of the
interventions they had selected to improve follow-up.Hospi-
tals additionally provided the costs of an average pair and the
cheapestpair of glasses available at the facility.Consensus fees
for typical postoperative medical and surgical interventions
(eg, anterior chamber washout, laser treatment) were set for
each region based on discussionswith partners. Total (hospi-
tal + patient) costs increasedwhen telephone callsweremade
but not with transportation subsidies because this aid could
be subtracted from patient costs.
Statistical Analysis
All VA data were converted to logMAR units. Counting fin-
gers, handmovements, light perception, and no light percep-
tionwere assigned logMAR values of 2.0, 2.3, 2.5, and 2.7, re-
spectively.Theestimatedexpectedeffectof the follow-upvisit
onVAwascalculatedas thedifferencebetweenUCVAandBCVA
for patients needing glasses, or half the number of lines from
theUCVA tonormalVA (6/6 = 0.0on the logMARscale) for pa-
tientswith treatablecomplications.Forexample, apatientwith
UCVA of 6/60 (logMAR scale, 1.0) and a treatable complica-
tionwas estimated to improve by 5 lines, because 10 lines are
between 1.0and0.0on the logMARscale.Theseanalyseswere
performedusingSTATAStatisticalSoftware (release12.0;Stata-
Corp). Mean willingness to pay for glasses was calculated
among those needing glasses using the following equation:
[(No. of Patients Who Bought Glasses × Mean Price Paid) +
(No. of Patients Without Glasses × Mean Price Willing to
Pay)]/No. of Patients Who Need Glasses
Cost-effectiveness analyses were performed using a decision
tree to analyze the following 4 strategies to promote patient
follow-up: (1) no follow-up (assumingnopatientswere exam-
ined at ≥40 days postoperatively); (2) patients return sponta-
neously after discharge for examination, but no interven-
tionswereperformed topromote follow-up; (3)patients return
spontaneously plus receive a telephone reminder for pa-
tients not returning by 40 days; and (4) patients return spon-
taneously plus receive a telephone reminder plus transporta-
tionsubsidies forpatientsnot returningby40days.Homevisits
were not included in analyses because these are not consid-
ered sustainable in routine clinical practice.
Apositivepatientoutcomeof follow-upwasdefinedashav-
ing at least 2 lines of improvement in VA in the eye undergo-
ing surgery if glasses or treatment was needed after the visit,
as calculatedabove. In the sensitivity analysis, only thosewho
wouldpay for carewere included (ie, expectedeffect),whereas
in the analysis of maximumpossible effect, we assumed that
all patients needing glasses, surgery, or medicines accepted
them (Figure).
Analyseswereperformedunderthefollowingassumptions.
Forstrategy1 (no follow-upafter40days),no treatmentofcom-
plicationswouldoccur, andanestimated 14%ofpatientsneed-
ingglasseswouldpurchasethemelsewherewithout thecostsof
thehospital visit. For strategies 2, 3, and4, an estimated 11%of
thosewhodidnot return for follow-upwouldpurchaseglasses.
These figuresarebasedonstudiesof spectaclepurchaseamong
patientswith cataract in China18 and Iran.19
For thosewith a complication requiring surgery, themean
price of surgery was added plus the cost of 2 extra visits and
theconsensuspriceofpostoperativemedication.Owing to the
relatively low prevalence of complications requiring treat-
ment (meanofmeans, 1.6% in total), global proportions of the
intervention type required (incisional surgery, 39.4%; laser
treatment, 15.2%; and medications, 45.5%) were applied for
calculations in each region, to avoid unstable estimates. Ow-
ing to incompletepatient responsesontheprice theywerewill-
ing to pay for treatment (with no responding patients willing
to pay for surgery), we assumed as a lower end for our sensi-
tivityanalysis thatonly thosepatientswithcomplications treat-
ablewithmedicationwould bewilling to pay and that all sur-
gical therapy would be refused.
Figure. Decision Tree Outline for Follow-up Strategy
Will get treatment (1) 
Will not get treatment (0)
No follow-up
Follow-up
Strategy
Need glasses (1) 
No need for glasses
or treatment (0)
Will not get glasses (0)
Will get treatment (1) 
Will not get treatment (0)
Need treatment (1)
Need glasses (1) 
No need for glasses
or treatment (0)
Will get glasses (1) 
Will not get glasses (0)
Need treatment (1)
Will get glasses (1) 
Sensitivity Analysis
Zero indicates no improvement (negative outcome); 1, improvement (positive
outcome).
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For all cost-effectiveness analyses, grand means (means
ofmeansof thedifferent countries)wereused toprevent coun-
tries withmore participants fromunduly influencing results.
All costswereconverted to internationaldollars,definedas the
amount of a currency required to purchase the samequantity
of goods and services asUS$1.00couldpurchase in theUnited
States,accordingtothepurchasingpowerparity indexonWorld
Bankwebsite.20Because follow-upvisits occurredduring less
than 1 year, no discounting was used. The incremental cost-
effectiveness ratio (ICER) was used to assess the cost-
effectivenessof each strategycomparedwith thepreviousone
(eg, spontaneous follow-upcomparedwithno follow-up). The
ICER was defined by the cost difference between 2 interven-
tions,dividedby thedifference in their effect, representing the
mean incremental cost for 1 improved patient. All cost-
effectivenessanalyseswereperformedusingTreeAgePro (ver-
sion 2011; TreeAge Software, Inc).
Results
Facilities and Patients
Twenty-seven hospitals in 8 countries participated, includ-
ing 14 in China, 5 in India, 2 in Eritrea, 2 inMexico, and 1 each
inVietnam, Ecuador, Guatemala, and Paraguay (eTable in the
Supplement).Medianannualcataractsurgicalvolumewas1820
(range, 42-91 759); 17 of 27 hospitals (63.0%)were public; and
11 of 27 (40.7%)were rural. Cost and follow-updatawere avail-
ableon2487patients (1068men[42.9%]; 1405women[56.5%];
14missing [0.6%];mean [SD] age, 68.4 [11.3] years), of whom
1177 (47.4%) were older than 70 years.
The follow-upvisit at least 40days after surgerywas com-
pleted for 2316patients (93.1%).Among these, 1201 (51.9%) re-
turned spontaneously, 708 (30.6%) after receiving interven-
tions (telephone calls or transportation subsidies), and 369
(15.9%)were examined at homeor a local facility. For surgical
data, 1769 (71.1%) underwent small-incision cataract surgery,
and 2022 (81.3%) had VA of 6/60 or worse in the operated-on
eye before surgery and had substantial improvements in VA
at the final postoperative visits (Table 1).
Cost and Utilization Information for theModels
Whenusing grandmeans, 75.3%of patients returned sponta-
neously and 56.0% needed glasses (Table 2). Of those need-
ing glasses and returning to the hospital, 56.9% were willing
to purchase them. The eFigure in the Supplement shows the
VA of patients needing glasses. The global mean amount pa-
tients were willing to pay for glasses was $49.73, approxi-
mately theglobalmeanpriceof the cheapest glasses. The total
amount patients were willing to pay for glasses was $11.57 in
Asia, $65.79 inLatinAmerica, and$99.92 inAfrica and fell be-
lowthemeanprice for inexpensiveglasses inChina, India,Para-
guay, andMexico (Table 3). Only a global mean of 1.6% of pa-
tientshad treatable surgical complications.Of those returning
to the hospital with a complication, a global mean of 39.4%
would accept treatment. Table 2 also shows regional varia-
tions in theneed for glasses (generallyhigher inLatinAmerica
and lower in Africa) and prevalence of complications.
Table 3 shows the costs of follow-up for patients and fa-
cilities and the local fees for treatments. Themeanglobal cost
of follow-up for patients was $50.50, with the lowest cost in
Asia ($16.00) andhighest inLatinAmerica ($75.80).Theglobal
cost for treatment increased from medicine ($16.50) to laser
treatment ($108.40) and incisional surgery ($217.00), al-
though the cost of a typical pair of glasses ($109.00) ex-
ceeded that of laser treatment globally and for each region ex-
ceptAsia (glasses, $36.70; laser treatment, $103.00) (Table 3).
Cost-effectivenessModeling
For the global and regional analyses, the greatest incremen-
tal effect in the proportion of patients achieving improvedVA
at follow-up ranged from0.08with no follow-up to 0.45with
spontaneous follow-up, with far smaller incremental effects
from adding telephone calls or transportation support (over-
all proportion, 0.53 for both) (Table 4). Overall ICERs were
$151.56, $164.46, and$133.05 for spontaneous follow-upalone,
with the telephone intervention, andwith the telephoneplus
transportation intervention, respectively. In our sensitivity
analyses,we foundthat the ICERwasmostaffectedbychanges
in the cost of the follow-up visit (ie, the expected effect, ac-
counting for willingness to pay for treatment). Interventions
increased theproportionof patientswith goodVAby less than
0.01 (ICER for transportation subsidy intervention, $206.47)
to 0.02 (ICER for telephone intervention, $456.22). Table 4
shows regional differences in these figures.
Discussion
Cataract surgery is widely considered a cost-effective proce-
dure in LMICs and rich countries,21-24 but our studies suggest
interventions to improvepostoperative follow-upmaynot be.
Cost-effectiveness of follow-up after other surgical proce-
dures has been studied, with inconsistent results, suggesting
that current follow-up regimens were appropriate in surgery
for bladder cancer25 but could be reduced after surgical resec-
tionof small cell lungcancer26 andafter adenotonsillectomy.27
The present study, however, is the first ofwhichwe are aware
to consider the cost-effectiveness of follow-up after cataract
surgery in LMICs and, in particular, of methods to encourage
patients to returnto theclinic forpostoperative follow-upwhen
these rates are low.13,14
Theprevious studyusingPRECOGdata14 reported thatVA
immediately after cataract surgerywashighly correlatedwith
VA after 40 days, suggesting that, for purposes of quality as-
sessment, follow-up of all patients is not needed. Other
investigators16,17 have suggested that postoperative fol-
low-up is important for achieving optimal visual results and
that facilities should invest in interventions to improve fol-
low-up where the rates are low. However, our results suggest
that thebenefit of such interventions in termsof improvedVA
is limited.
In the present study, 52.7% of patients returned sponta-
neously to the hospital after 40 days (or 75.3% when a mean
ofmeans analysiswasused to reduce the effect of China’s low
30%follow-uprate).Of thesepatients,nearly two-thirdswould
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benefit from glasses (58.2%) or treatment of complications
(1.5%) (Table 2). Approximately 60% of these patients would
accept suchsight-improvingcare.Thosewhoreturnedonlyaf-
ter telephone or transportation interventions were generally
lesswilling to accept or pay for glasses and treatment. In other
words, requesting patients at discharge to return for fol-
low-up was effective becausemost of the patients benefiting
fromfollow-upreturnedspontaneously, resulting ina lowyield
Table 1. Patient Demographic Characteristics and Clinical Outcomesa
Characteristics
No. (%) of Patients by Country
China
(n = 1242)
India
(n = 504)
Vietnam
(n = 103)
Ecuador
(n = 100)
Guatemala
(n = 98)
Mexico
(n = 205)
Paraguay
(n = 99)
Eritrea
(n = 136)
Total
(N = 2487)
Sex
Male 553 (44.5) 199 (39.5) 36 (35.0) 30 (30.0) 43 (43.9) 101 (49.3) 48 (48.5) 58 (42.6) 1068 (42.9)
Female 689 (55.5) 305 (60.5) 53 (51.4) 70 (70.0) 55 (56.1) 104 (50.7) 51 (51.5) 78 (57.4) 1405 (56.5)
Missing 0 0 14 (13.6) 0 0 0 0 0 14 (0.6)
Age, y
≤50 49 (3.9) 94 (18.7) 1 (1.0) 15 (15.0) 10 (10.2) 7 (3.4) 6 (6.1) 12 (8.8) 194 (7.8)
51-60 123 (9.9) 211 (41.9) 7 (6.8) 13 (13.0) 11 (11.2) 49 (23.9) 12 (12.1) 22 (16.2) 448 (18.0)
61-70 302 (24.3) 169 (33.5) 29 (28.2) 17 (17.0) 18 (18.4) 51 (24.9) 21 (21.2) 59 (43.4) 666 (26.8)
>71 768 (61.8) 30 (6.0) 64 (62.1) 55 (55.0) 59 (60.2) 98 (47.8) 60 (60.6) 43 (31.6) 1177 (47.3)
Missing 0 0 2 (1.9) 0 0 0 0 0 2 (0.1)
Type of surgery
SICS 925 (74.5) 448 (88.9) 6 (5.8) 72 (72.0) 98 (100) 6 (2.9) 96 (97.0) 118 (86.8) 1769 (71.1)
ECCE\ICCE 27 (2.2) 23 (4.6) 6 (5.8) 28 (28.0) 0 36 (17.6) 2 (2.0) 18 (13.2) 140 (5.6)
Phacoemulsification 276 (22.2) 32 (6.3) 89 (86.4) 0 0 162 (79.0) 1 (1.0) 0 560 (22.5)
Missing 14 (1.1) 1 (0.2) 2 (1.9) 0 0 1 (0.5) 0 0 18 (0.7)
Follow-up visit occurred
Yes 1110 (89.4) 473 (93.8) 101 (98.1) 100 (100) 97 (99.0) 202 (98.5) 97 (98.0) 136 (100) 2316 (93.1)
No 132 (10.6) 31 (6.2) 2 (1.9) 0 1 (1.0) 3 (1.5) 2 (2.0) 0 171 (6.9)
Missing 0 0 0 0 0 0 0 0 0
Time from discharge to
follow-up, median
(5th-95th percentile), d
162
(59-445)
109
(87-175)
75
(50-112)
82
(59-108)
65
(42-99)
81
(60-290)
84
(33-233)
73
(54-144)
107
(56-372)
Preoperative UCVA
≤6/60 1082 (87.1) 340 (67.5) 98 (95.1) 73 (73.0) 61 (62.2) 158 (77.1) 79 (79.8) 131 (96.3) 2022 (81.3)
>6/60 to <6/18 131 (10.5) 105 (20.8) 1 (1.0) 24 (24.0) 27 (27.6) 36 (17.6) 16 (16.2) 1 (0.7) 341 (13.7)
≥6/18 13 (1.0) 59 (11.7) 1 (1.0) 3 (3.0) 9 (9.2) 11 (5.4) 3 (3.0) 4 (2.9) 103 (4.1)
Missing 16 (1.3) 0 3 (2.9) 0 1 (1.0) 0 1 (1.0) 0 21 (0.8)
UCVA at ≥40 d after surgery
≤6/60 57 (4.6) 24 (4.8) 28 (27.2) 2 (2.0) 5 (5.1) 26 (12.7) 15 (15.2) 19 (14.0) 176 (7.1)
>6/60 to <6/18 324 (26.1) 115 (22.8) 23 (22.3) 12 (12.0) 29 (29.6) 30 (14.6) 38 (38.4) 35 (25.7) 606 (24.4)
≥6/18 729 (58.7) 334 (66.3) 50 (48.5) 86 (86.0) 63 (64.3) 146 (71.2) 44 (44.4) 82 (60.3) 1534 (61.7)
Missing 132 (10.6) 31 (6.2) 2 (1.9) 0 1 (1.0) 3 (1.5) 2 (2.0) 0 171 (6.9)
Postoperative complication
present
Yes 20 (1.6) 3 (0.6) 3 (2.9) 1 (1.0) 2 (2.0) 12 (5.9) 5 (5.1) 9 (6.6) 55 (2.2)
No 1054 (84.9) 470 (93.2) 95 (92.2) 98 (98.0) 94 (95.9) 183 (89.3) 88 (88.9) 127 (93.4) 2209 (88.8)
Missing 168 (13.5) 31 (6.2) 5 (4.9) 1 (1.0) 2 (2.0) 10 (4.9) 6 (6.1) 0 223 (99.0)
Follow-up strategy at ≥40 d
after surgery (among those
with follow-up data)
Spontaneous 335 (30.2) 229 (48.4) 63 (62.4) 96 (96.0) 93 (95.9) 195 (96.5) 94 (96.9) 96 (70.6) 1201 (51.9)
After telephone call or
transport support
491 (44.2) 127 (26.8) 35 (34.7) 4 (4.0) 4 (4.1) 6 (3.0) 1 (1.0) 40 (29.4) 708 (30.6)
Visit performed in outside
facility or at home
252 (22.7) 117 (24.7) 0 0 0 0 0 0 369 (15.9)
Missing 32 (2.9) 0 3 (3.0) 0 0 1 (0.5) 2 (2.1) 0 38 (1.6)
Abbreviations: ECCE, extracapsular cataract extraction; ICCE, intracapsular cataract extraction; SICS, small-incision cataract surgery; UCVA, uncorrected visual acuity.
a Percentages have been rounded andmay not total 100.
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of interventions aiming to improveVAoutcomesby further in-
creasing follow-up rates.
Policymakersseekingtoapplytheseresultsshouldbeaware
of regional differences in our results, however. Thehighglobal
Table 2. Proportion of PatientsWith Potential Benefit FromPostoperative CareWhoWould Accept Treatmenta
Follow-up Strategy
Proportion of Patients
Overall
Glasses Treatment of Complications
Need Purchasedb Need Acceptedc
All Regions
None
Follow-up NA NA NA NA NA
No follow-up 100 56.0 14.0d 1.6 0
Spontaneous
Follow-up 75.3 58.2 61.2 1.5 39.4
No follow-up 24.7 39.5 11.0d 1.0 0
Spontaneous + telephone intervention
Follow-up 93.2 56.2 56.9 1.6 39.4
No follow-up 7.8 46.1 11.0d 0.2 0
Spontaneous + telephone + transportation
intervention
Follow-up 94.0 56.3 56.9 1.6 39.4
No follow-up 6.0 43.8 11.0d 0.3 0
Asia
None
Follow-up NA NA NA NA NA
No follow-up 100 53.7 14.0d 0.9 0
Spontaneous
Follow-up 47.9 55.7 58.6 1.1 39.4
No follow-up 52.1 50.9 11.0d 0.7 0
Spontaneous + telephone intervention
Follow-up 81.8 54.3 48.4 1.0 39.4
No follow-up 18.2 46.11 11.0d 0.2 0
Spontaneous + telephone + transportation
intervention
Follow-up 83.9 54.5 48.4 0.9 39.4
No follow-up 16.1 43.8 11.0d 0.3 0
Latin America
No follow-up
Follow-up NA NA NA NA NA
No follow-up 100 64.8 14d 1.8 0
Spontaneous
Follow-up 97.0 65.2 63.8 1.7 39.4
No follow-up 3.0 39.6 11.0d 0 0
Spontaneous + telephone intervention
Follow-up 100 64.8 62.8 1.7 39.4
No follow-up 0 NA NA NA NA
Africa
No follow-up
Follow-up NA NA NA NA NA
No follow-up 100 27.9 14.0d 3.22 0
Spontaneous
Follow-up 70.6 37.5 77.8 2.0 39.4
No follow-up 29.4 5.0 11.0d 6.1 0
Spontaneous + telephone intervention
Follow-up 100 27.9 78.9 3.22 39.4
No follow-up 0 NA NA NA NA
Abbreviation: NA, not applicable.
a All proportions are grandmeans
(themean of individual country
means, to moderate the effect of
larger country cohorts) and derived
from the Prospective Review of
Early Cataract Outcomes and
Grading data set apart unless
otherwise indicated.
bCalculated from the proportion who
need glasses (sensitivity analysis).
c Calculated from the proportion who
need treatment for a complication
(sensitivity analysis); 39.4% of the
patients with a treatable
complication could be treated with
medication.
dBased on data from Congdon et al18
and Hashemi et al.19
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meancostperpatient improvedfrominterventionssuchas tele-
phonecalls and transportation supportmaybe comparedwith
theICER$52.05(spontaneous + telephoneinterventions) inAsia
(in thebest casewhereallpatientsacceptedpostoperativecare)
becauseof the lowcostof glasses and transportation there.Re-
ductioninthecostofglassesandtreatmentofcomplicationsdue
togovernment, insurance,orotherexternalsubsidiesorbyother
means, suchas theuseof ready-madespectacles,28would likely
improve acceptance and thus the effect on VA and cost-
effectiveness.However,otherbarriersbesidescost, suchasdis-
comfortandlackofperceivedneed,29havebeenshowntoreduce
adult use of spectacles in LMICs.
Approximately one-third (27.9% in Africa) to almost
two-thirds (64.8% in Latin America) of patients could ben-
efit from glasses for residual postoperative refractive error.
Because all hospitals used A-scans and keratometry for
intraocular lens selection, these regional differences could
reflect differing quality of the preoperative measurements,
more limited stocks of intraocular lenses in some settings, or
a tendency in some areas to aim for more myopic distance
correction to improve uncorrected near VA. In addition, the
definition of benefiting from glasses used herein was an
improvement of 2 lines with correction in the eye undergo-
ing surgery. Thus, we cannot infer that all or even most of
these patients had impaired VA without glasses. A previous
study18 reported that only 35% of patients with a similar
2-line improvement in VA in rural China would accept pre-
scriptions, mostly owing to a lack of perceived need. None-
theless, because only 5 of 40 hospitals in PRECOG (12.5%)
reached the World Health Organization standard (80% of
patients with uncorrected VA of 6/18 or better),14 invest-
ments in better biometric measurements and more complete
stocks of intraocular lenses could improve this rate.
A common approach in assessment of cost-effectiveness
is the use of cost per quality-adjusted life-year, where a year
lived isweighedby theutility score,which represents thequal-
ity of life during that year.30 Use of utility scores for vision re-
search is controversial and the outcome is susceptible to cul-
tural differences,31 suggesting that this approach is not well
suited to the present study.
Strengths and Limitations
Strengths of our study included a high participation rate
(>90%), a large sample size, and inclusion of a broad range
of countries and hospital types. Furthermore, this is the first
large study, to our knowledge, to collect data on direct
patient and hospital costs for care after cataract surgery in
LMICs. Limitations must also be acknowledged. Lack
of data for near vision and the need for inexpensive
reading glasses will lead to an underestimate of the cost-
Table 3. Costs of Follow-up After Cataract Surgery andWillingness to Pay for Gaining Visual Improvementa
Region
Cost of Spontaneous Follow-up
Visit for Patient, $
Costs of Treatment for Complications
and Glasses, $
Willingness to Pay for Glasses Among
Those Who Need Themc
Medical Otherb Total Medicine Laser Surgery
Glasses
No. Who
Need
Glasses/
Total No.
(%)
Willing to
Pay, % of
Patientsd
Amount
Willing to
Pay, $eAverage Cheap
All, mean
(median)
17.30
(6.95)
33.20
(31.40)
50.50
(36.30)
16.50
(16.50)
108.40
(88.00)
217.00
(176.00)
109.00
(48.20)
47.60
(25.50)
56.0
(61.2)
72.0
(79.9)
49.73
(33.64)
Asia, mean
(median)
2.55
(2.28)
13.40
(8.34)
16.00
(9.60)
8.00
(8.00)
103.00
(57.00)
207.00
(114.00)
36.70
(28.50)
16.30
(14.40)
53.7
(63.4)
57.3
(39.2)
11.57
(12.64)
China,
mean
4.10 7.80 11.90 8.00 232.00 464.00 59.90 23.60 364/1110
(32.8)
38.1 12.64
Vietnam,
mean
2.28 24.10 26.40 8.00 57.10 114.00 28.50 10.90 64/101
(63.4)
94.7 15.29
India,
mean
1.26 8.34 9.60 8.00 21.10 41.20 21.50 14.40 307/473
(64.9)
39.2 6.79
Latin
America,
mean
(median)
31.20
(20.00)
44.60
(49.80)
75.80
(68.70)
25.00
(25.00)
132.10
(101.00)
264.00
(202.00)
142.00
(102.00)
60.20
(42.90)
64.8
(61.9)
81.2
(83.9)
65.79
(53.19)
Ecuador,
mean
7.51 38.70 46.20 25.00 109.00 212.00 36.36 27.30 53/100
(53.0)
86.9 51.99
Paraguay,
mean
30.40 60.80 91.20 25.00 243.00 487.00 32.44 16.20 63/97
(64.9)
62.2 11.68
Guatemala,
mean
9.63 10.70 20.30 25.00 92.50 185.00 331.27 139.00 80/97
(82.5)
80.9 145.11
Mexico,
mean
77.10 68.20 145.00 25.00 83.50 167.00 167.00 58.50 119/202
(58.9)
94.7 54.39
Eritrea
(Africa),
mean
6.39 46.60 53.00 8.00 28.50 57.10 194.00 91.30 38/136
(27.9)
78.9 99.92
a Costs are calculated in international dollars, defined as the amount of a
currency required to purchase the same quantity of goods and services as US
$1.00 could purchase in the United States, according to the purchasing power
parity index onWorld Bank website.20
b Includes round-trip transportation costs, food and living expenses, and loss of
wages for patient and accompanying persons.
c Includes patients with distance vision improving by at least 2 lines.
d Includes percentage of patients who had already bought glasses plus the
percentage of those still needing glasses whowere willing to purchase them.
e Defined as fraction of patients willing to pay somethingmultiplied by the
mean price they are willing to pay.
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effectiveness of the postoperative care strategies, although
such data are unlikely to have changed our conclusion about
the limited visual effect of interventions to increase follow-
up. Our use of the actual price paid for glasses to estimate
willingness to pay for spectacles was likely an underesti-
mate (patients might have been willing to pay more than
they did). Finally, few data were available from participants
on willingness to pay for treatment of complications
because of the low prevalence (1.6%) of complications in
our cohort. However, this low prevalence also meant that
the influence of these figures on our conclusions was likely
modest.
Table 4. Cost and Effect of Different Strategies to Promote Follow-up Visits After Cataract Surgerya
Follow-up Strategy
Cost per
Patient, $
Incremental
Cost per
Patient, $
Patients Achieving
Improved Vision IncrementalCost per 1
Improved
Patient, $Proportion
Incremental
Proportion
All Regions
Maximum possible effectb
None 3.63 NA 0.08 NA NA
Spontaneous 59.79 56.17 0.45 0.37 151.56
Spontaneous + telephone intervention 72.89 13.09 0.53 0.08 164.46
Spontaneous + telephone +
transportation intervention
73.51 0.62 0.53 0.00 133.07
Expected effectc
None 3.63 NA 0.08 NA NA
Spontaneous 49.85 46.22 0.27 0.20 232.69
Spontaneous + telephone intervention 59.67 9.83 0.30 0.02 456.22
Spontaneous + telephone +
transportation intervention
60.18 0.51 0.30 0.00 206.47
Asia
Maximum possible effectb
None 1.15 NA 0.07 NA NA
Spontaneous 12.39 11.24 0.28 0.21 53.00
Spontaneous + telephone intervention 20.19 7.80 0.43 0.15 52.05
Spontaneous + telephone +
transportation intervention
20.70 0.51 0.44 0.01 44.72
Expected effectc
None 1.15 NA 0.07 NA NA
Spontaneous 10.02 8.87 0.18 0.11 84.07
Spontaneous + telephone intervention 15.70 5.68 0.21 0.04 153.53
Spontaneous + telephone +
transportation intervention
16.10 0.40 0.22 0.00 80.67
Latin America
Maximum possible effectb
None 5.40 NA 0.09 NA NA
Spontaneous 114.51 109.12 0.64 0.55 197.32
Spontaneous + telephone intervention 117.63 3.12 0.66 0.01 229.78
Expected effectc
None 5.40 NA 0.09 NA NA
Spontaneous 96.95 91.55 0.41 0.32 287.61
Spontaneous + telephone intervention 99.24 2.30 0.41 0.00 111 258.15
Africa
Maximum possible effectb
None 3.57 NA 0.04 NA NA
Spontaneous 63.20 59.63 0.28 0.24 246.88
Spontaneous + telephone intervention 81.86 18.65 0.31 0.03 602.59
Expected effectc
None 3.57 NA 0.04 NA NA
Spontaneous 56.41 52.84 0.21 0.17 303.60
Spontaneous + telephone intervention 73.28 16.88 0.23 0.02 839.13
Abbreviation: NA, not applicable.
a Costs are calculated in international
dollars, defined as the amount of a
currency required to purchase the
same quantity of goods and services
as US $1.00 could purchase in the
United States, according to the
purchasing power parity index on
World Bank website.20
bAssumes that all needing treatment
or glasses would accept.
c Treatment with medicine but not
surgery or laser treatment is
accepted and only those with
glasses or who are willing to pay the
price of the cheapest available
glasses are considered as achieving
improved vision.
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Conclusions
Follow-upshouldbeencouragedatdischargeafter cataract sur-
gery,butefforts to increase returnrateswhere follow-up ispoor
do not create value for the patient or for society, largely be-
cause most patients who could benefit returned to the clinic
spontaneouslywhen requestedatdischarge todo so.Most im-
portant, this finding is robust to the inclusion of the patient’s
willingness to pay for additional correction as a cost to thepa-
tient. Governmental authorities and not-for-profit founda-
tions developing programs to reduce the burden of visual im-
pairment byoffering cataract surgery inLMICs can focus their
scarce resources on case finding, patient education, and im-
provementofpostoperative refractiveerror to reduce theneed
for prescription glasses.
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